Literature DB >> 33609131

The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients.

Vincenzo La Milia1, Silvia Tonolo2, Francesco Luzzaro2, Claudio Bonato3, Andrea Cavalli1, Barbara Foglieni4, Consuelo Debiase1, Monica Limardo1, Selena Longhi1, Chiara Ravasi1, Sara Viganò1.   

Abstract

Entities:  

Year:  2021        PMID： 33609131      PMCID： PMC7928722          DOI： 10.1093/ndt/gfab047

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19.

Authors:  Dominique Bertrand; Mouad Hamzaoui; Laurent Drouot; Julie Lamulle; Mélanie Hanoy; Stéphane Edet; Charlotte Laurent; Ludivine Lebourg; Isabelle Etienne; Mathilde Lemoine; Frank Le Roy; Dorian Nezam; Eleusis Mauger; Olivier Boyer; Dominique Guerrot; Sophie Candon
Journal:  Transplant Direct       Date:  2021-11-17

2.  SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.

Authors:  Henri Boulanger; Salima Ahriz Saksi; Jedjiga Achiche; Florence Batusanski; Nicolas Stawiarski; Ali Diddaoui; Luc Fromentin; Mokhtar Chawki
Journal:  Int J Nephrol       Date:  2021-12-01

3.  Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?

Authors:  Vincenzo La Milia; Silvia Tonolo; Francesco Luzzaro; Claudio Bonato; Monica Limardo; Selena Longhi; Chiara Ravasi; Sara Viganò; Andrea Cavalli
Journal:  Clin Kidney J       Date:  2022-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.